FLURIZAN

Details for Australian Trade Mark No. 1072374 (hide)

Owner Myriad Genetics, Inc. a Delaware corporation

Convention US 9 May 2005 78/626013

Service Cullen & Co

Various Convention priority claimed: 9 May 2005, United States of America, No. 78/626013 in respect of PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF VERY MILD DEMENTIA OF THE ALZHEIMER'S TYPE, ALSO KNOWN AS MILD COGNITIVE IMPAIRMENT (MCI) OR PRO

Filing Date 29 August 2005

Classes

Class 5 Pharmaceutical preparations, including pharmaceutical preparations for the prevention and treatment of very mild dementia of the alzheimer's type, also known as mild cognitive impairment (MCI) or prodromal alzheimer's disease, and mild, moderate, and severe dementia of the alzheimer's type

Event Publications

22 September 2005 Application filed

24 November 2005 Application Accepted

16 March 2006 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1072375

1072373